Ivantis Completes a $46.5 MM Financing; Company Receives Approval to Expand US Pivotal Trial for Novel Glaucoma Device

13 January 2014

One of the largest medical device financings of the past year in the US; funds will support multiple clinical trials, including recently expanded US pivotal trial for novel glaucoma device IRVINE, Calif.–(BUSINESS WIRE)–Ivantis, developer of the novel Hydrus® Microstent device designed to lower eye pressure for glaucoma patients, announced today that it secured an additional […]

Continue Reading